Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: Is further therapy warranted?
Publication
, Journal Article
Sarma, D; Hwang, ES
Published in: Breast Diseases
January 1, 2014
Duke Scholars
Published In
Breast Diseases
DOI
EISSN
1878-1918
ISSN
1043-321X
Publication Date
January 1, 2014
Volume
25
Issue
4
Start / End Page
325 / 326
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sarma, D., & Hwang, E. S. (2014). Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: Is further therapy warranted? Breast Diseases, 25(4), 325–326. https://doi.org/10.1016/j.breastdis.2014.10.018
Sarma, D., and E. S. Hwang. “Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: Is further therapy warranted?” Breast Diseases 25, no. 4 (January 1, 2014): 325–26. https://doi.org/10.1016/j.breastdis.2014.10.018.
Sarma D, Hwang ES. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: Is further therapy warranted? Breast Diseases. 2014 Jan 1;25(4):325–6.
Sarma, D., and E. S. Hwang. “Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: Is further therapy warranted?” Breast Diseases, vol. 25, no. 4, Jan. 2014, pp. 325–26. Scopus, doi:10.1016/j.breastdis.2014.10.018.
Sarma D, Hwang ES. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: Is further therapy warranted? Breast Diseases. 2014 Jan 1;25(4):325–326.
Published In
Breast Diseases
DOI
EISSN
1878-1918
ISSN
1043-321X
Publication Date
January 1, 2014
Volume
25
Issue
4
Start / End Page
325 / 326
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences